DK1697405T3 - LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria - Google Patents

LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria

Info

Publication number
DK1697405T3
DK1697405T3 DK04804433.3T DK04804433T DK1697405T3 DK 1697405 T3 DK1697405 T3 DK 1697405T3 DK 04804433 T DK04804433 T DK 04804433T DK 1697405 T3 DK1697405 T3 DK 1697405T3
Authority
DK
Denmark
Prior art keywords
antigen
stage
lsa
plasmodium falciparum
vaccines against
Prior art date
Application number
DK04804433.3T
Other languages
English (en)
Inventor
Pierre Druilhe
Karima Brahimi-Zeghidour
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK1697405T3 publication Critical patent/DK1697405T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK04804433.3T 2003-12-15 2004-12-15 LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria DK1697405T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03293158A EP1544211A1 (en) 2003-12-15 2003-12-15 LSA-5 pre-erythrocytic stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
PCT/EP2004/014848 WO2005058948A1 (en) 2003-12-15 2004-12-15 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria

Publications (1)

Publication Number Publication Date
DK1697405T3 true DK1697405T3 (da) 2013-01-02

Family

ID=34486470

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04804433.3T DK1697405T3 (da) 2003-12-15 2004-12-15 LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria

Country Status (9)

Country Link
US (1) US8765145B2 (da)
EP (2) EP1544211A1 (da)
JP (1) JP4991308B2 (da)
CN (1) CN1922202A (da)
BR (1) BRPI0417286A (da)
CA (1) CA2548792C (da)
DK (1) DK1697405T3 (da)
WO (1) WO2005058948A1 (da)
ZA (1) ZA200604958B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100982064B1 (ko) * 2006-03-28 2010-09-13 원광대학교산학협력단 말라리아 원충에 대한 단일클론 항체 및 이를 이용한말라리아의 진단방법
CN101603964A (zh) * 2009-07-10 2009-12-16 中国海洋大学 海产品中异尖线虫的酶联免疫检测方法
CA2769996C (en) * 2009-11-05 2018-06-12 The United States Of America As Represented By The Secretary Of The Na Plasmodium falciparum sporozoite and liver stage antigens
US9321834B2 (en) 2013-12-05 2016-04-26 Leidos, Inc. Anti-malarial compositions
WO2016084944A1 (ja) * 2014-11-28 2016-06-02 国立大学法人 群馬大学 熱帯熱マラリア原虫のエノラーゼタンパク質の部分配列を用いた人工抗原とその製造方法
JP2019516741A (ja) * 2016-05-19 2019-06-20 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア マラリア感染症を予防及び治療するための合成マラリア免疫原、その組み合わせ、及びそれらの使用
CN113144222B (zh) * 2021-04-14 2023-05-23 台州学院 外泌体用于防止脑型疟疾发生的实验方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566780B1 (fr) 1984-07-02 1987-02-06 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un epitope caracteristique d'une proteine produite par des cellules infectees par les parasites du paludisme et compositions les contenant
US20020076769A1 (en) * 2000-08-03 2002-06-20 Richard Brady Reduced molecular weight galactomannans oxidized by galactose oxidase
EP1201250A1 (en) * 2000-10-25 2002-05-02 SMITHKLINE BEECHAM BIOLOGICALS s.a. Immunogenic compositions comprising liver stage malarial antigens

Also Published As

Publication number Publication date
EP1697405B1 (en) 2012-09-05
CA2548792C (en) 2014-07-08
EP1697405A1 (en) 2006-09-06
EP1544211A1 (en) 2005-06-22
BRPI0417286A (pt) 2007-04-10
CN1922202A (zh) 2007-02-28
JP2008504005A (ja) 2008-02-14
JP4991308B2 (ja) 2012-08-01
US8765145B2 (en) 2014-07-01
CA2548792A1 (en) 2005-06-30
ZA200604958B (en) 2007-11-28
WO2005058948A1 (en) 2005-06-30
US20100183590A1 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
EP1708748A4 (en) INFLUENZA IMMUNOGENS AND VACCINES
NO20052426D0 (no) Fremgangsmater for vaksinasjon mot malaria
NO20035208D0 (no) Nytt vaksine preparat
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
EP1603590A4 (en) INFLUENZA VIRUS VACCINE
ATE553776T1 (de) Multivalente impfstoffzusammensetzung
CY2016018I1 (el) Εμβολιο κατα του ιου του δυτικου νειλου
FR14C0016I2 (fr) Vacccin west nile
DK1163000T3 (da) Vacciner imod antigener fra bakterier
WO2006029887A3 (en) Vaccines comprising plasmodium antigens
DK1356822T3 (da) Farmaceutiske sammensætninger, der forøger immunogeniteten af svagt immunogene antigener
AU2003302240A8 (en) Plasmodium falciparum antigens and methods of use
DK1697405T3 (da) LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria
ATE437656T1 (de) Impfstoff gegen das maul- und klauensäure-virus
AU2003278175A8 (en) Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
IL177903A0 (en) Infectious bursal disease virus antigenic isolates and vaccines
AU2002304480A1 (en) Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
ATE524735T1 (de) Impfstoff zur vorbeugung gegen malaria
IS2797B (is) Bóluefni gegn ISA-veiru
AU2001262996A1 (en) Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum
IL193391A0 (en) Influenza antigens, vaccine compositions, and related methods
TH79424B (th) วัคซีน
DK1573012T3 (da) Rekombinant virusbaserede malariavacciner
NO20012126D0 (no) HIV-vaksine
HU0402690D0 (en) Hiv virus antigen deprived of its virulence for manufacturing vaccine